Company intelligence / Profile preview

Pantheon Vision

Baltimore, Maryland, United Statespantheonvision.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Pantheon Vision has made significant progress in developing and refining its proprietary bioengineered corneal implant. The company has completed three meetings with the FDA, received positive regulatory feedback, secured intellectual property milestones, and presented at major conferences. It aims to enter clinical development soon but remains pre-clinical as of mid–2025. Total funding raised to date exceeds $4 million, primarily from KeraLink International.

Therapeutic areas: Ophthalmology
Modalities: Device (bioengineered corneal implant)Polymer-based implant
Industry: Implantable Medical Devices

Partnerships

Eyedeal Medical Technology Co., Ltd. (manufacturing/collaboration partner for polymer materials and device production)

Beyond the preview

Go deeper on Pantheon Vision.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pantheon Vision.

Explore the full profile